U.S. Luxury Stock News

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

When close to half the companies operating in the Insurance industry in the United States have price-to-sales ratios...

Gray Media, Inc.'s ( NYSE:GTN ) stock was strong despite it releasing a soft earnings report last week. However, we...

AdvanSix Inc.'s ( NYSE:ASIX ) stock didn't jump after it announced some healthy earnings. Our analysis showed that...

We'd be surprised if Matrix Service Company ( NASDAQ:MTRX ) shareholders haven't noticed that the President of...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Some Lemonade, Inc. ( NYSE:LMND ) shareholders may be a little concerned to see that the CFO, Principal Accounting...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...

Investors were disappointed with Flotek Industries, Inc.'s ( NYSE:FTK ) earnings, despite the strong profit numbers. We...

Smurfit Westrock Plc's ( NYSE:SW ) earnings announcement last week was disappointing for investors, despite the decent...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Whilst it may not be a huge deal, we thought it was good to see that the Medalist Diversified REIT, Inc. ( NASDAQ:MDRR...

Voyager Therapeutics, Inc. ( NASDAQ:VYGR ) shares have retraced a considerable 26% in the last month, reversing a fair...

Investors who take an interest in Arq, Inc. ( NASDAQ:ARQ ) should definitely note that the CEO, President & Director...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Key Insights Quantum-Si's significant retail investors ownership suggests that the key decisions are influenced by...

Earlier this month, Cytek Biosciences reported third-quarter 2025 earnings, showing revenue of US$52.29 million and a net loss of US$5.48 million compared to net income in the prior year, and reaffirmed its full-year revenue guidance of US$196 million to US$205 million. This combination of improved quarterly revenue but a swing to quarterly and year-to-date losses provided investors with contrasting signals about Cytek’s ongoing financial health and outlook. We’ll review how the...

Autolus Therapeutics (AUTL) just released its latest quarterly earnings and is drawing increased investor attention thanks to several key developments. The company continues to expand commercial access for Obe-cel, reports strong manufacturing results, and anticipates new data at the upcoming ASH conference. See our latest analysis for Autolus Therapeutics. Autolus Therapeutics has seen a burst of activity lately, from broadening commercial access and updating its leadership team to advancing...

Anavex Life Sciences (AVXL) reported that its lead drug candidate, blarcamesine, for early Alzheimer's disease faced a negative trend vote from the European Medicines Agency's CHMP. This outcome has sparked new questions about regulatory pathways and next steps for the company. See our latest analysis for Anavex Life Sciences. Anavex’s regulatory news contributed to a dramatic shift in sentiment, with the stock’s 1-day share price return tumbling 35.94% and momentum clearly fading. Despite...

On November 13, 2025, Endava and Paysafe announced a multi-year partnership to accelerate smarter payments and community engagement, alongside Paysafe's updated earnings guidance and expanded share buyback authorization following the release of wider quarterly net losses and an increase in buyback plan terms. The coordinated focus on technology-driven payments and increased buyback authorization underscores ongoing efforts by Paysafe to enhance operational resilience, signal management...

Infinity Natural Resources, Inc. recently announced a $75 million share repurchase program alongside the release of third quarter 2025 earnings, which showed year-over-year revenue growth but a substantial decrease in net income. The company also narrowed its 2025 production guidance to the higher end of its prior range, signaling increased operational focus and management confidence. We’ll explore how the buyback initiative reinforces Infinity Natural Resources’ investment narrative in...

Applied Therapeutics released its third quarter 2025 earnings, reporting revenue of US$1 million and a net loss of US$18.99 million, both improved from the previous year; the company also announced Executive Chairman John Johnson's resignation for personal reasons. The sizable reduction in net losses and increased revenue, alongside leadership changes unconnected to business issues, may shape future corporate priorities. We'll explore how Applied Therapeutics' narrowing quarterly losses...

Sunrise Communications (OTCPK:SNRE.Y) has just reported its third-quarter and nine-month results. The company highlighted a sharp drop in net losses, even as sales dipped slightly compared to last year. Investors are eyeing these improved bottom-line numbers closely. See our latest analysis for Sunrise Communications. Despite the year kicking off with a surge, Sunrise Communications' share price has pulled back recently, delivering a 23.32% year-to-date share price return and a 19.93% total...

In the past week, Korro Bio announced a significant restructuring aimed at extending its cash runway, including a workforce reduction of approximately 34%, alongside an update on its Phase 1/2a REWRITE clinical trial for KRRO-110 in AATD, which showed acceptable safety but did not meet expected efficacy thresholds. These announcements coincide with the temporary pause of its collaboration with Novo Nordisk and the resignation of its Chief Medical Officer, highlighting a period of transition...